SCHEMBL7312451

SCHEMBL7312451

COc1ccc2c(c1)C(=Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)C(=O)N2C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK4 O00444 1/20 0.52
EEF2K O00418 1/20 0.47
SRC P12931 1/20 0.47
EGFR P00533 2/20 0.46
LCK P06239 3/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 1/20 0.45
PRKACA P17612 1/20 0.45
PRKACG P22612 1/20 0.45
PRKACB P22694 1/20 0.45
ERBB2 P04626 1/20 0.44
IGF1R P08069 1/20 0.44
CTRC Q99895 1/20 0.43
LRRK2 Q5S007 2/20 0.42
SIRT1 Q96EB6 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
PTGS1 P23219 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7312445 1.00 PLK4 (0.52) PLK4EEF2KSRCEGFRLCK
SCHEMBL9251015 0.88 EEF2K (0.46) PLK4EEF2KSRCEGFRLCK
SCHEMBL7370909 0.82 ERBB2 (0.57) EEF2KSRCEGFRMEN1ALDH1A1
SCHEMBL7370906 0.82 ERBB2 (0.57) EEF2KSRCEGFRMEN1ALDH1A1
SCHEMBL8539596 0.76 EEF2K (0.41) PLK4EEF2KSRCEGFRMEN1
SCHEMBL8544169 0.75 EEF2K (0.47) PLK4EEF2KSRCEGFRMEN1
SCHEMBL8544637 0.74 EEF2K (0.46) PLK4EEF2KSRCEGFRMEN1
SCHEMBL8539973 0.74 EGFR (0.44) EEF2KSRCEGFRERBB2IGF1R
SCHEMBL8544618 0.74 EEF2K (0.48) PLK4EEF2KSRCEGFRLCK
SCHEMBL8545505 0.73 EEF2K (0.44) PLK4EEF2KSRCEGFRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5124347-A Inhibits 5-lipoxygenase and cyclooxygenase; for treatment of allergies, arthritis, pain WARNER-LAMBERT CO. (US) 1992-06-23 US claimed
US-6420428-B1 TREATING HEPATITIS C AND HEPATIC FIBROSIS USING 2,6-DI-TERT-BUTYLPHENOL DERIVATIVES; EFFECTIVE IN SUBJECTS WITH INTERFERON INSUSCEPTIBILITY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-07-16 US disclosed
US-6369097-B1 Treatment and prevention of hepatic disorders THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-04-09 US disclosed
US-6348493-B1 TREATMENT OF HEPATITIS C BY ADMINISTERING 2,6-DI-TER-BUTYLPHENOL THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-02-19 US disclosed
US-6218437-B1 ADMINISTERING A THERAPEUTIC AMOUNT OF DI-TERT-BUTYLPHENOL DERIVATIVE TO SUBJECT UNDER CONDITIONS SUCH THAT SAID SYMPTOMS ARE DIMINISHED THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-04-17 US disclosed
US-5124347-A Inhibits 5-lipoxygenase and cyclooxygenase; for treatment of allergies, arthritis, pain WARNER-LAMBERT CO. (US) 1992-06-23 US disclosed